These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31542220)

  • 41. Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure.
    Kim JE; Sinn DH; Choi GS; Kim JM; Joh JW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Liver Dis; 2021 Aug; 53(8):1004-1010. PubMed ID: 33931340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
    Yan H; Jin S; Liang L; Du J; Aithal GP; Li L
    Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510
    [No Abstract]   [Full Text] [Related]  

  • 43. Risk prediction scores for acute on chronic liver failure development and mortality.
    Mahmud N; Hubbard RA; Kaplan DE; Taddei TH; Goldberg DS
    Liver Int; 2020 May; 40(5):1159-1167. PubMed ID: 31840390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
    Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
    Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience.
    O'Leary JG; Bajaj JS; Tandon P; Biggins SW; Wong F; Kamath PS; Garcia-Tsao G; Maliakkal B; Lai J; Fallon M; Vargas HE; Thuluvath P; Subramanian R; Thacker LR; Reddy KR
    Liver Transpl; 2019 Apr; 25(4):571-579. PubMed ID: 30724010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic review: role of elevated plasma von-Willebrand factor as predictor of mortality in patients with chronic liver disease.
    Eidelberg A; Kirubakaran R; Nair SC; Eapen CE; Elias E; Goel A
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1184-1191. PubMed ID: 31498279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis.
    Wang SJ; Yin S; Gu WY; Zhang Y; Li H
    J Dig Dis; 2018 Oct; 19(10):614-625. PubMed ID: 30226019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications.
    Staufer K; Roedl K; Kivaranovic D; Drolz A; Horvatits T; Rasoul-Rockenschaub S; Zauner C; Trauner M; Fuhrmann V
    Liver Int; 2017 Jun; 37(6):843-850. PubMed ID: 28211257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.
    Sundaram V; Kogachi S; Wong RJ; Karvellas CJ; Fortune BE; Mahmud N; Levitsky J; Rahimi RS; Jalan R
    J Hepatol; 2020 Mar; 72(3):481-488. PubMed ID: 31669304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.
    Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM
    Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histopathologic Evaluation of Acute on Chronic Liver Failure.
    Nacif LS; Aquino F; Tanigawa RY; Zanini LY; Pinheiro RS; Rocha-Santos V; Martino RB; Song A; Arantes RM; Ducatti L; Waisberg DR; Galvão FH; Andraus W; Alves VAF; Carneiro-D'Albuquerque L
    Transplant Proc; 2020 Jun; 52(5):1325-1328. PubMed ID: 32204897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
    Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP
    Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.
    Narciso-Schiavon JL; Pereira JG; Silva TE; Bansho ETO; Morato EF; Pinheiro JT; Muraro-Wildner L; Bazzo ML; Dantas-Corrêa EB; Schiavon LL
    Ann Hepatol; 2017; 16(5):780-787. PubMed ID: 28809733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.
    Ruiz-Margáin A; Pohlmann A; Ryan P; Schierwagen R; Chi-Cervera LA; Jansen C; Mendez-Guerrero O; Flores-García NC; Lehmann J; Torre A; Macías-Rodríguez RU; Trebicka J
    Liver Transpl; 2018 May; 24(5):595-605. PubMed ID: 29476704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
    Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
    J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
    J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Li TP; Guan SH; Wang Q; Chen LW; Yang K; Zhang H
    World J Gastroenterol; 2019 Oct; 25(37):5667-5675. PubMed ID: 31602166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the prognostic value of Chronic Liver Failure Consortium scores and traditional models for predicting mortality in patients with cirrhosis.
    Antunes AG; Teixeira C; Vaz AM; Martins C; Queirós P; Alves A; Velasco F; Peixe B; Oliveira AP; Guerreiro H
    Gastroenterol Hepatol; 2017 Apr; 40(4):276-285. PubMed ID: 28222896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre and post-liver transplant outcome of cirrhotic patients with acute on chronic liver failure.
    Iacob S; Ghioca M; Csiki IE; Tomescu D; Droc G; Hrehoret D; Brasoveanu V; Pietrareanu C; Iacob R; Gheorghe C; Popescu I; Gheorghe L
    Medicine (Baltimore); 2020 Oct; 99(44):e22419. PubMed ID: 33126299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis.
    Piano S; Tonon M; Vettore E; Stanco M; Pilutti C; Romano A; Mareso S; Gambino C; Brocca A; Sticca A; Fasolato S; Angeli P
    J Hepatol; 2017 Dec; 67(6):1177-1184. PubMed ID: 28733221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.